Although the topical application of MC903 to mouse skin recapitulates the features of AD, such as inflammation, itching, barrier dysfunction, and elevated serum IgE, the generation of skin inflammation does not require the presence of mature B and T lymphocytes, which are the effector cells driving AD progression (30). This evidence concerns the gene IGHE and Alzheimer disease.